Joint Formulary & PAD

Secukinumab - Hidradenitis suppurativa

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :

No records returned.

Associated Icons :
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Secukinumab
Indication :
Hidradenitis suppurativa
Group Name :
Keywords :
Brand Names Include :
Cosentyx
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Secukinumab is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hidradenitis suppurativa.

Committee Recommendations (1)

19 Sep 23 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication